Skip to content
★ Sign in to follow
EL
Insider activity · 24 months0 buys4 salesCumulative net flow
Total declarations
34
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (25 ops.)
€1.3M

Latest filing published 19 Aug 2026 for Replimune Group, Inc., €114k.

Filing timeline

BuySale
Emily Luisa Hill

Insider track record

Disclosed buys
0
Disclosed sells
25

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Emily Luisa Hill: trading record in brief

Emily Luisa Hill is a declared insider at 2 companies (finance chief); the most frequent names are PTC Therapeutics, Inc. and Replimune Group, Inc. Between 6 January 2020 and 17 August 2026, the trades on record add up to 34 filings.

Sales make up the whole of the open-market record (25 sales, €1.3M). Other entries cover 9 share grants. In 2026 alone, the filings show no purchases and 2 sales.

On 19 August 2026 came the latest disclosure, an open-market sale for €114k in Replimune Group, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Emily Luisa Hill

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations21 total

21 of 21 declarations